상세 보기
IMbrave050: Phase 3 study of adjuvant atezolizumab plus bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following resection or ablation
- Trojan, J.;
- Chow, P.;
- Chen, M.;
- Cheng, A-L;
- Kaseb, A.;
- ... Tak, W-Y;
- 외 17명
Citations
WEB OF SCIENCE
0- 제목
- IMbrave050: Phase 3 study of adjuvant atezolizumab plus bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following resection or ablation
- 저자
- Trojan, J.; Chow, P.; Chen, M.; Cheng, A-L; Kaseb, A.; Kudo, M.; Lee, H. C.; Yopp, A.; Zhou, J.; Wang, L.; Wen, X.; Heo, J.; Tak, W-Y; Nakamura, S.; Numata, K.; Uguen, T.; Hsieh, D.; Cha, E.; Hack, S. P.; Lian, Q.; Spahn, J.; Wu, C.; Qin, S.
- 발행일
- 2023-10-03
- 유형
- Meeting Abstract
- 권
- 46
- 페이지
- 239 ~ 239
- 언어
- ENG
- 출판사
- KARGER
- 발행국가
- 스위스
- 분량
- 1 페이지
- ISSN
- E 2296-5262
P 2296-5270